Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.

ABSTRACT: The high cost of drug development and the narrow spectrum of coverage typically provided by direct-acting antivirals limit the scalability of this antiviral approach. This review summarizes progress and challenges in the repurposing of approved kinase inhibitors as host-targeted broad-spectrum antiviral therapies.

SUBMITTER: Schor S 

PROVIDER: S-EPMC5804095 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature